Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$54.02 - $63.83 $8.04 Million - $9.51 Million
-148,922 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$55.56 - $60.79 $2.1 Million - $2.29 Million
37,711 Added 33.91%
148,922 $8.94 Million
Q2 2021

Aug 16, 2021

SELL
$48.42 - $60.18 $3.24 Million - $4.03 Million
-66,919 Reduced 37.57%
111,211 $6.67 Million
Q1 2021

May 17, 2021

SELL
$47.16 - $54.44 $29,474 - $34,025
-625 Reduced 0.35%
178,130 $8.9 Million
Q4 2020

Feb 12, 2021

BUY
$48.52 - $58.02 $1.08 Million - $1.3 Million
22,332 Added 14.28%
178,755 $8.97 Million
Q3 2020

Nov 12, 2020

SELL
$53.07 - $61.1 $1.4 Million - $1.61 Million
-26,297 Reduced 14.39%
156,423 $8.62 Million
Q2 2020

Aug 14, 2020

SELL
$43.1 - $55.31 $2.36 Million - $3.03 Million
-54,709 Reduced 23.04%
182,720 $9.67 Million
Q1 2020

May 13, 2020

BUY
$37.79 - $51.33 $1.96 Million - $2.66 Million
51,894 Added 27.97%
237,429 $10.6 Million
Q4 2019

Feb 13, 2020

SELL
$42.46 - $50.46 $323,672 - $384,656
-7,623 Reduced 3.95%
185,535 $9.28 Million
Q3 2019

Nov 13, 2019

BUY
$40.12 - $45.47 $765,650 - $867,749
19,084 Added 10.96%
193,158 $8.75 Million
Q2 2019

Aug 14, 2019

SELL
$37.28 - $41.68 $1.36 Million - $1.52 Million
-36,553 Reduced 17.35%
174,074 $7.14 Million
Q1 2019

May 15, 2019

BUY
$35.49 - $43.02 $2.55 Million - $3.09 Million
71,724 Added 51.64%
210,627 $9.05 Million
Q4 2018

Feb 13, 2019

BUY
$36.86 - $41.49 $2.24 Million - $2.52 Million
60,681 Added 77.58%
138,903 $5.25 Million
Q3 2018

Nov 13, 2018

BUY
$34.76 - $39.72 $2.07 Million - $2.37 Million
59,573 Added 319.44%
78,222 $3.11 Million
Q1 2018

May 15, 2018

SELL
$32.97 - $36.63 $45,004 - $49,999
-1,365 Reduced 6.82%
18,649 $655,000
Q4 2017

Feb 14, 2018

SELL
$32.09 - $34.78 $46,979 - $50,917
-1,464 Reduced 6.82%
20,014 $694,000
Q2 2017

Aug 14, 2017

BUY
N/A
21,478
21,478 $733,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $208B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Amp Capital Investors LTD Portfolio

Follow Amp Capital Investors LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

News

Stay updated on Amp Capital Investors LTD with notifications on news.